Report cover image

Global Biological Assets Valuation Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jan 27, 2023
Length 114 Pages
SKU # LPI17669520

Description

Global Biological Assets Valuation Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Biological Assets Valuation Industry Forecast” looks at past sales and reviews total world Biological Assets Valuation sales in 2022, providing a comprehensive analysis by region and market sector of projected Biological Assets Valuation sales for 2023 through 2029. With Biological Assets Valuation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Assets Valuation industry.

This Insight Report provides a comprehensive analysis of the global Biological Assets Valuation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biological Assets Valuation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Assets Valuation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Assets Valuation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Assets Valuation.

The global Biological Assets Valuation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Biological Assets Valuation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Biological Assets Valuation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Biological Assets Valuation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Biological Assets Valuation players cover Roma Group, BMI Appraisals, PwC, Deloitte, AVISTA Group, Huashen Enterprise Management Consulting Co., Ltd., Simosol, FRC and Savills, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Assets Valuation market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Plant Assets
Animal Assets

Segmentation by application
Biological Asset Management
Biological Asset Transaction
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roma Group
BMI Appraisals
PwC
Deloitte
AVISTA Group
Huashen Enterprise Management Consulting Co., Ltd.
Simosol
FRC
Savills
Tilhill
John Clegg & Co
Landfor
Milliken Forestry
Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd.
Beijing Zhongruicheng Assets Appraisal Company
Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd.

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

114 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biological Assets Valuation Market Size 2018-2029
2.1.2 Biological Assets Valuation Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Biological Assets Valuation Segment by Type
2.2.1 Plant Assets
2.2.2 Animal Assets
2.3 Biological Assets Valuation Market Size by Type
2.3.1 Biological Assets Valuation Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Biological Assets Valuation Market Size Market Share by Type (2018-2023)
2.4 Biological Assets Valuation Segment by Application
2.4.1 Biological Asset Management
2.4.2 Biological Asset Transaction
2.4.3 Other
2.5 Biological Assets Valuation Market Size by Application
2.5.1 Biological Assets Valuation Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Biological Assets Valuation Market Size Market Share by Application (2018-2023)
3 Biological Assets Valuation Market Size by Player
3.1 Biological Assets Valuation Market Size Market Share by Players
3.1.1 Global Biological Assets Valuation Revenue by Players (2018-2023)
3.1.2 Global Biological Assets Valuation Revenue Market Share by Players (2018-2023)
3.2 Global Biological Assets Valuation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biological Assets Valuation by Regions
4.1 Biological Assets Valuation Market Size by Regions (2018-2023)
4.2 Americas Biological Assets Valuation Market Size Growth (2018-2023)
4.3 APAC Biological Assets Valuation Market Size Growth (2018-2023)
4.4 Europe Biological Assets Valuation Market Size Growth (2018-2023)
4.5 Middle East & Africa Biological Assets Valuation Market Size Growth (2018-2023)
5 Americas
5.1 Americas Biological Assets Valuation Market Size by Country (2018-2023)
5.2 Americas Biological Assets Valuation Market Size by Type (2018-2023)
5.3 Americas Biological Assets Valuation Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Assets Valuation Market Size by Region (2018-2023)
6.2 APAC Biological Assets Valuation Market Size by Type (2018-2023)
6.3 APAC Biological Assets Valuation Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biological Assets Valuation by Country (2018-2023)
7.2 Europe Biological Assets Valuation Market Size by Type (2018-2023)
7.3 Europe Biological Assets Valuation Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biological Assets Valuation by Region (2018-2023)
8.2 Middle East & Africa Biological Assets Valuation Market Size by Type (2018-2023)
8.3 Middle East & Africa Biological Assets Valuation Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biological Assets Valuation Market Forecast
10.1 Global Biological Assets Valuation Forecast by Regions (2024-2029)
10.1.1 Global Biological Assets Valuation Forecast by Regions (2024-2029)
10.1.2 Americas Biological Assets Valuation Forecast
10.1.3 APAC Biological Assets Valuation Forecast
10.1.4 Europe Biological Assets Valuation Forecast
10.1.5 Middle East & Africa Biological Assets Valuation Forecast
10.2 Americas Biological Assets Valuation Forecast by Country (2024-2029)
10.2.1 United States Biological Assets Valuation Market Forecast
10.2.2 Canada Biological Assets Valuation Market Forecast
10.2.3 Mexico Biological Assets Valuation Market Forecast
10.2.4 Brazil Biological Assets Valuation Market Forecast
10.3 APAC Biological Assets Valuation Forecast by Region (2024-2029)
10.3.1 China Biological Assets Valuation Market Forecast
10.3.2 Japan Biological Assets Valuation Market Forecast
10.3.3 Korea Biological Assets Valuation Market Forecast
10.3.4 Southeast Asia Biological Assets Valuation Market Forecast
10.3.5 India Biological Assets Valuation Market Forecast
10.3.6 Australia Biological Assets Valuation Market Forecast
10.4 Europe Biological Assets Valuation Forecast by Country (2024-2029)
10.4.1 Germany Biological Assets Valuation Market Forecast
10.4.2 France Biological Assets Valuation Market Forecast
10.4.3 UK Biological Assets Valuation Market Forecast
10.4.4 Italy Biological Assets Valuation Market Forecast
10.4.5 Russia Biological Assets Valuation Market Forecast
10.5 Middle East & Africa Biological Assets Valuation Forecast by Region (2024-2029)
10.5.1 Egypt Biological Assets Valuation Market Forecast
10.5.2 South Africa Biological Assets Valuation Market Forecast
10.5.3 Israel Biological Assets Valuation Market Forecast
10.5.4 Turkey Biological Assets Valuation Market Forecast
10.5.5 GCC Countries Biological Assets Valuation Market Forecast
10.6 Global Biological Assets Valuation Forecast by Type (2024-2029)
10.7 Global Biological Assets Valuation Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Roma Group
11.1.1 Roma Group Company Information
11.1.2 Roma Group Biological Assets Valuation Product Offered
11.1.3 Roma Group Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Roma Group Main Business Overview
11.1.5 Roma Group Latest Developments
11.2 BMI Appraisals
11.2.1 BMI Appraisals Company Information
11.2.2 BMI Appraisals Biological Assets Valuation Product Offered
11.2.3 BMI Appraisals Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BMI Appraisals Main Business Overview
11.2.5 BMI Appraisals Latest Developments
11.3 PwC
11.3.1 PwC Company Information
11.3.2 PwC Biological Assets Valuation Product Offered
11.3.3 PwC Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 PwC Main Business Overview
11.3.5 PwC Latest Developments
11.4 Deloitte
11.4.1 Deloitte Company Information
11.4.2 Deloitte Biological Assets Valuation Product Offered
11.4.3 Deloitte Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Deloitte Main Business Overview
11.4.5 Deloitte Latest Developments
11.5 AVISTA Group
11.5.1 AVISTA Group Company Information
11.5.2 AVISTA Group Biological Assets Valuation Product Offered
11.5.3 AVISTA Group Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AVISTA Group Main Business Overview
11.5.5 AVISTA Group Latest Developments
11.6 Huashen Enterprise Management Consulting Co., Ltd.
11.6.1 Huashen Enterprise Management Consulting Co., Ltd. Company Information
11.6.2 Huashen Enterprise Management Consulting Co., Ltd. Biological Assets Valuation Product Offered
11.6.3 Huashen Enterprise Management Consulting Co., Ltd. Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Huashen Enterprise Management Consulting Co., Ltd. Main Business Overview
11.6.5 Huashen Enterprise Management Consulting Co., Ltd. Latest Developments
11.7 Simosol
11.7.1 Simosol Company Information
11.7.2 Simosol Biological Assets Valuation Product Offered
11.7.3 Simosol Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Simosol Main Business Overview
11.7.5 Simosol Latest Developments
11.8 FRC
11.8.1 FRC Company Information
11.8.2 FRC Biological Assets Valuation Product Offered
11.8.3 FRC Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 FRC Main Business Overview
11.8.5 FRC Latest Developments
11.9 Savills
11.9.1 Savills Company Information
11.9.2 Savills Biological Assets Valuation Product Offered
11.9.3 Savills Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Savills Main Business Overview
11.9.5 Savills Latest Developments
11.10 Tilhill
11.10.1 Tilhill Company Information
11.10.2 Tilhill Biological Assets Valuation Product Offered
11.10.3 Tilhill Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Tilhill Main Business Overview
11.10.5 Tilhill Latest Developments
11.11 John Clegg & Co
11.11.1 John Clegg & Co Company Information
11.11.2 John Clegg & Co Biological Assets Valuation Product Offered
11.11.3 John Clegg & Co Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 John Clegg & Co Main Business Overview
11.11.5 John Clegg & Co Latest Developments
11.12 Landfor
11.12.1 Landfor Company Information
11.12.2 Landfor Biological Assets Valuation Product Offered
11.12.3 Landfor Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Landfor Main Business Overview
11.12.5 Landfor Latest Developments
11.13 Milliken Forestry
11.13.1 Milliken Forestry Company Information
11.13.2 Milliken Forestry Biological Assets Valuation Product Offered
11.13.3 Milliken Forestry Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Milliken Forestry Main Business Overview
11.13.5 Milliken Forestry Latest Developments
11.14 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd.
11.14.1 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd. Company Information
11.14.2 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd. Biological Assets Valuation Product Offered
11.14.3 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd. Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd. Main Business Overview
11.14.5 Yunnan Linhai Forest Resources Assets Appraisal Co., Ltd. Latest Developments
11.15 Beijing Zhongruicheng Assets Appraisal Company
11.15.1 Beijing Zhongruicheng Assets Appraisal Company Company Information
11.15.2 Beijing Zhongruicheng Assets Appraisal Company Biological Assets Valuation Product Offered
11.15.3 Beijing Zhongruicheng Assets Appraisal Company Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Beijing Zhongruicheng Assets Appraisal Company Main Business Overview
11.15.5 Beijing Zhongruicheng Assets Appraisal Company Latest Developments
11.16 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd.
11.16.1 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd. Company Information
11.16.2 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd. Biological Assets Valuation Product Offered
11.16.3 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd. Biological Assets Valuation Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd. Main Business Overview
11.16.5 Beijing Zhongqi Zeyuan Assets Appraisal Co., Ltd. Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us